Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
European Journal of Medicinal Chemistry|March 25, 2024
Lipidation and PEGylation Strategies to Prolong the in Vivo Half-Life of a Nanomolar EphA4 Receptor AntagonistMaricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.European Journal of Medicinal Chemistry|November 4, 2024
Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonistMaricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.Bioorganic & Medicinal Chemistry Letters|June 8, 2013
Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAPRobert J Ardecky, Kate Welsh, Darren Finlay, et al.Bioorganic & Medicinal Chemistry Letters|June 18, 2011
Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAPMarcos González-López, Kate Welsh, Darren Finlay, et al.Neurobiology of Disease|November 1, 2023
Exploring the heterogeneous transcriptional response of the CNS to systemic LPS and Poly(I:C)Daniel Bormann, Dragan Copic, Katharina Klas, et al.ACS Chemical Biology|January 18, 2013
Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAPMitchell Vamos, Kate Welsh, Darren Finlay, et al.American Journal of Human Genetics|November 27, 2010
Whole-exome-sequencing-based discovery of human FADD deficiencyAlexandre Bolze, Minji Byun, David McDonald, et al.Acta Neuropathologica|September 16, 2023
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosisAnnika Hofmann, Nik Krajnc, Assunta Dal-Bianco, et al.Nature Neuroscience|November 5, 2024
Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesionsCelia Lerma-Martin, Pau Badia-I-Mompel, Ricardo O Ramirez Flores, et al.Cell|February 5, 2013
Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesisLi Ma, Yongzhen Tao, Angeles Duran, et al.Pageof 9